The global in vitro fertilization (IVF) banking services market is expected to witness substantial growth over the next decade, driven by increasing infertility rates, delayed childbearing, and rising awareness of fertility preservation options. IVF banking services encompass the storage of eggs, sperm, and embryos in cryogenic facilities for future use, offering individuals greater flexibility and peace of mind in their reproductive planning.
With advancements in cryopreservation techniques, improved success rates, and growing acceptance of IVF procedures, the demand for banking services is steadily rising. Additionally, supportive regulatory frameworks and the growing availability of affordable banking packages are making these services more accessible to a wider audience.
As more individuals and couples turn to IVF as a reliable option for family planning, the IVF banking services market is poised for significant expansion through 2035. In 2025, the global in vitro fertilization banking services market is estimated to be valued at approximately USD 5,263.7 Million. By 2035, it is projected to reach around USD 13,652.7 Million, reflecting a compound annual growth rate (CAGR) of 10.0%.
Key Market Metrics
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 5,263.7 Million |
| Projected Market Size in 2035 | USD 13,652.7 Million |
| CAGR (2025 to 2035) | 10.0% |
Explore FMI!
Book a free demo
North America continues to dominate the market for IVF banking services, backed by a well-established healthcare infrastructure, widespread awareness levels, and considerable investments in reproductive technologies. In particular, egg and embryo banking services are in greater demand in the United States and Canada, spurred on by delayed parenthood trends and increasing IVF procedure success rates.
Another significant market is Europe, where IVF is widely accepted, regulations are conducive, and cryopreservation methods are technologically advanced. Countries such as Germany, the United Kingdom and France lead in offering a broad range of IVF banking services that are accessible to a wide demographic. Furthermore, increasing focus on fertility preservation and reproductive health in the region will also help to propel the market growth.
IVF banking services are growing the fastest in Asia-Pacific region due to rising rate of infertility and changing social structure along with advancements in health care sector. Strong demand for these services is due to increasing awareness as well as growing medical tourism and advancements in reproductive technology in countries like China, Japan, and India. With the increasing affordability and accessibility, this region will be a lucrative market for the growth of the global market.
Challenges
High Costs, Ethical Concerns, and Regulatory Compliance
The in vitro fertilization (IVF) banking services market is faced with the challenge of high cryopreservation costs with embryo storage and genetic screening. Most fertility preservation services continue to be expensive and inaccessible for middle- and lower-income patients. Moreover, the ethical aspects related to embryo freezing and the storage of donor sperm/egg and long-term cryopreservation can trigger legal and moral debates, more so in areas with stringent reproductive laws.
Another major challenge is regulatory compliance, which requires fertility clinics and IVF banks to comply with strict regulations concerning embryo viability, donor screening and cryogenic storage standards, as set forth by FDA (USA), HFEA (UK), ESHRE (Europe), and other national health authorities, resulting in higher operating costs and administrative complexity.
Opportunities
Growth in Fertility Preservation, AI-Powered IVF Solutions, and International Medical Tourism
Amidst these difficulties, factors like increasing need for fertility preservation and increasing acceptance of AI-driven optimization of IVF and international fertility tourism are driving exponential growth in the IVF banking services market. As these individuals are opting for delayed parenthood, the demand for egg, sperm, and embryo cryopreservation services are increasing.
Innovative approaches, like AI-driven IVF techniques, automated embryo selection, and predictive analytics for implantation success along with cry storage monitoring technologies, are enhancing efficiency as well as pregnancy outcomes at fertility clinics. Fertility tourism is also contributing to of fertility tourism in some markets, particularly those that offer cheaper IVF treatments with more flexible regulations, as people look beyond their home countries in search of affordable high-quality reproductive care.
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Compliance with FDA, HFEA, and ESHRE guidelines for cryopreservation, donor screening, and embryo storage. |
| Consumer Trends | Demand for egg, sperm, and embryo freezing due to career planning, medical treatments, and lifestyle choices. |
| Industry Adoption | High use of liquid nitrogen-based cryopreservation, vitrification techniques, and manual embryo grading. |
| Supply Chain and Sourcing | Dependence on fertility clinics, third-party cryobanks , and donor gamete networks. |
| Market Competition | Dominated by IVF clinics, specialized cryobanks , and reproductive health companies. |
| Market Growth Drivers | Growth fueled by increased infertility rates, career-focused reproductive planning, and LGBTQ+ family-building support. |
| Sustainability and Environmental Impact | Moderate adoption of eco-friendly cryogenic storage solutions and digitalized patient records. |
| Integration of Smart Technologies | Early adoption of AI-based sperm/egg analysis, cloud-based patient management, and remote IVF consultations. |
| Advancements in Reproductive Medicine | Development of improved cryopreservation protocols, hormone-free IVF, and PGT (preimplantation genetic testing). |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Stricter AI-driven compliance tracking, genetic screening regulations, and ethical governance for fertility banking. |
| Consumer Trends | Growth in AI-driven embryo viability assessment, genetic health preservation, and personalized fertility storage plans. |
| Industry Adoption | Expansion into AI-assisted cryogenic storage, blockchain -based donor tracking, and fully automated IVF lab management. |
| Supply Chain and Sourcing | Shift toward AI-optimized gamete storage networks, cross-border fertility banking, and real-time cryostorage monitoring. |
| Market Competition | Entry of AI-powered reproductive tech firms, gene-editing fertility startups, and blockchain -based fertility banking solutions. |
| Market Growth Drivers | Accelerated by AI-enhanced embryo selection, remote fertility consultations, and global cryostorage network expansion. |
| Sustainability and Environmental Impact | Large-scale shift toward low-energy cryostorage , AI-assisted sustainable lab management, and carbon-neutral IVF facilities. |
| Integration of Smart Technologies | Expansion into AI-powered embryo selection, blockchain -enabled fertility records, and real-time cryostorage condition monitoring. |
| Advancements in Reproductive Medicine | Evolution toward gene therapy-assisted fertility treatments, AI-customized embryo selection, and regenerative medicine applications in IVF. |
With increasing infertility rates, rising demand for egg/sperm preservation services, and growth of assisted reproductive technologies (ART), the USA IVF banking services market is achieving steady growth. Demand in the market is being driven by the increasing availability of fertility preservation services through career-focused couples and cancer patients receiving chemotherapy. Moreover, rise in the number of fertility clinics, coverage of insurance and advancements in cryopreservation methods are aiding the growth of the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 10.2% |
The UK IVF Banking Services market is vigorously growing due to increasing awareness regarding fertility preservation, growing availability of egg and sperm freezing services, and supportive government policies governing the ART procedures. Other factors contributing to increased market demand are the increasing trend of delayed parenthood among women, the increasing use of fertility solutions.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 9.8% |
The IVF banking services market is expanding throughout the European Union due in part to increasingly generous government-sponsored fertility preservation programs, emerging commercial demand for donor sperm and eggs, and advancing vitrification technology. The expansion of the market is also attributed to the rising medical tourism to low-cost IVF treatments and the increasing accessibility of fertility services under the national healthcare plans.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 10.0% |
Japan IVF banking services market is in moderate growth because of drop in birth rate population, high infertile person’s population and high usage of cryopreservation methods. Growing productivity of working women and government initiatives like financial aids to the patients undergoing IVF procedure will drive the market growth. Moreover, technology-driven innovations over embryo storage and genetic screening are influencing future industry growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 9.9% |
In South Korea, the IVF banking services market is currently undergoing significant growth, driven by the surging governmental support for IVF and ART procedures, rising accessibility of embryo and gamete preservation services, as well as increasing social acceptance towards ART among younger married couples. So is the demand for advanced freezing techniques, donor egg banks and surrogacy-friendly policies. Moreover, the market growth is further promoted by the use of AI in embryo selection and smart IVF monitoring solutions.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 10.1% |
The IVF banking services market is predicted to witness a notable growth over the forecast period owing to the growing adoption of fertility preservation solutions, advancing assisted reproductive technologies (ART), and the growing number of infertility patients requiring egg banking services.
The process of egg banking is an essential aspect of IVFs, allowing individuals to freeze and preserve their eggs for future use, and also providing intended parents with high-quality eggs from donors for the process of assisted reproduction. From better cryopreservation techniques and access to fertility services to more women joining egg donation programs, egg banking is on the rise globally. The market's segments include Service Type (Egg Banking).
Realizing the importance of the egg banking services as a part of the IVF Industry, nearly all (IFV) systems have incorporated Egg Vanking/Freezing as a counter part of their services which helps this segment to generate maximum revenue among the market segments. The two main branches of the segment include personal egg banking (also known as oocyte cryopreservation) and donor egg banking.
Oocyte cryopreservation (the process of freezing eggs) has become widely accepted for women who wish to delay childbearing by using frozen eggs in the future. Later marriage and childbearing, as well as medical conditions that affect fertility, along with lifestyle decisions, have driven up demand for fertility preservation. Until recently, egg freezing was not a reliable option for women seeking to have children later in life, but advances in vitrification a method of
Freezing that dramatically improves egg survival rates during freeze and thaw are making personal egg banking a viable solution for women who want a larger reproductive window.
Banking of donor eggs is also growing rapidly, especially with regard to infertile couples, single parents, and couples in the LGBTQ+ communities. Donor egg banks freeze, pre-screen, and maintain well-matched donor eggs that can be shipped worldwide, offering convenience and accessibility to intended parents. Fertility clinics and IVF centers are increasingly adopting donor egg banking.
Growing demand for fertility preservation, embryo storage, and advanced reproductive technologies are driving the growth of the IVF banking services market. Over 10% of women of reproductive age struggle with infertility globally, and rising infertility rates coupled with delayed parenting trends, growing egg and sperm freezing rates, and advanced AI powered reproduction technology adoption are driving growth. Companies are now targeting success rates, accessibility, and patient convenience with AI-enhanced cryopreservation, personalized IVF treatment plans, and secure long-term storage solutions.
Market Share Analysis by Key Players & IVF Banking Service Providers
| Company Name | Estimated Market Share (%) |
|---|---|
| Cryoport, Inc. | 18-22% |
| Vitrolife AB | 12-16% |
| Thermo Fisher Scientific Inc. | 10-14% |
| CooperSurgical, Inc. | 8-12% |
| Coriell Institute for Medical Research | 5-9% |
| Other IVF Banking Service Providers (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Cryoport, Inc. | Provides AI-optimized cryogenic storage, safe transport of embryos and reproductive cells, and cloud-based fertility preservation tracking . |
| Vitrolife AB | Specializes in advanced cryopreservation, AI-enhanced embryo selection, and high-quality IVF consumables . |
| Thermo Fisher Scientific Inc. | Offers AI-powered storage solutions, next-generation embryo freezing techniques, and automated IVF laboratory equipment . |
| CooperSurgical, Inc. | Focuses on AI-assisted embryo grading, fertility preservation, and reproductive cell banking technologies . |
| Coriell Institute for Medical Research | Develops secure and AI-driven biological specimen storage solutions for long-term fertility preservation . |
Key Market Insights
Cryoport, Inc. (18-22%)
Cryoport leads the IVF banking services market, offering AI-enhanced cryogenic storage, safe reproductive material transportation, and cloud-based fertility tracking solutions.
Vitrolife AB (12-16%)
Vitrolife specializes in advanced embryo freezing, ensuring AI-powered embryo selection and improved IVF success rates.
Thermo Fisher Scientific Inc. (10-14%)
Thermo Fisher provides state-of-the-art cryopreservation, optimizing AI-driven embryo storage security and long-term fertility preservation.
CooperSurgical, Inc. (8-12%)
CooperSurgical focuses on personalized IVF treatments, integrating AI-assisted embryo grading and reproductive cell banking innovations.
Coriell Institute for Medical Research (5-9%)
Coriell develops biological specimen storage solutions, ensuring AI-powered long-term fertility preservation and research-driven reproductive health advancements.
Other Key Players (30-40% Combined)
Several fertility centers, reproductive healthcare providers, and cryopreservation technology companies contribute to next-generation IVF banking innovations, AI-powered fertility preservation solutions, and secure reproductive material storage services. These include:
The overall market size for the in vitro fertilization (IVF) banking services market was USD 5,263.7 Million in 2025.
The in vitro fertilization (IVF) banking services market is expected to reach USD 13,652.7 Million in 2035.
Growth is driven by the rising prevalence of infertility, increasing awareness of fertility preservation, advancements in cryopreservation techniques, and growing acceptance of assisted reproductive technologies (ART).
The top 5 countries driving the development of the in vitro fertilization (IVF) banking services market are the USA, China, Germany, India, and Japan.
Egg Banking and Sperm Banking Services are expected to command a significant share over the assessment period.
The Prurigo Nodularis (PN) Treatment Market is segmented by product, and end user from 2025 to 2035
Warm Autoimmune Hemolytic Anemia (WAIHA) Treatment Market Analysis by Drug Class, Distribution Channel, and Region through 2035
Atrophic Vaginitis Treatment Market Analysis And Forecast by Diagnosis, Treatment, Therapy Type, Distribution Channel, and Region through 2035
Adrenal Crisis Management Market Analysis and Forecast, By Diagnosis Method, Treatment Method, Distribution Channel, and Region, through 2035
Birch Allergy Treatment Market Analysis by Drug Class, Route of Administration, Distribution Channel and Region: Forecast from 2025 to 2035
Cancer Vaccines Market Analysis by Technology, Treatment Method, Application and Region from 2025 to 2035
In Vitro Fertilization Banking Services Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
